Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04622683 · ClinicalTrials.gov registry record · NA

Effects of Hepatic Ultrasound on Metabolic Homeostasis

A NA study of Healthy and Insulin Resistance, sponsored by Yale University.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT04622683 is a NA study of Healthy and Insulin Resistance that has completed, run by Yale University. The registered enrollment target is 37 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04622683, a NA study of Healthy and Insulin Resistance, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to define the effect of ultrasound exposure of the liver in the region of the porta hepatis on glucose homeostasis and insulin resistance in healthy subjects.

Interventions

  • PROCEDURE Ultrasound

Study Locations (1)

Connecticut

  • Yale-New Haven Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2021-01-01
Est. Completion 2023-09-13
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04622683

The ClinicalTrials.gov registry entry for NCT04622683 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.

NCT04622683 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04622683 about?

NCT04622683 is a clinical study titled "Effects of Hepatic Ultrasound on Metabolic Homeostasis". The purpose of this study is to define the effect of ultrasound exposure of the liver in the region of the porta hepatis on glucose homeostasis and insulin resistance in healthy subjects.

What is the current status of trial NCT04622683?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2021-01-01. Estimated completion is 2023-09-13.

What conditions does trial NCT04622683 study?

This clinical trial studies the following conditions: Healthy, Insulin Resistance.

What interventions are being tested in trial NCT04622683?

The interventions under investigation include: Ultrasound (PROCEDURE).

Who is sponsoring clinical trial NCT04622683?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04622683 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.